Hinge Bio
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $31M
Investors
- 3
About Hinge Bio
Based in California, US, Hinge Bio, Inc. operates as a biotechnology company that develops therapeutics for autoimmunity, cancer, inflammatory diseases, and infectious diseases. In January 2025, Hinge Bio, Inc. The company specializes in developing therapeutics utilizing its proprietary GEM-DIMER™ platform, which addresses challenges in the treatment of autoimmunity, cancer, inflammatory diseases, and infectious diseases. The GEM-DIMER™ technology enables cooperative binding to disease targets, resulting in enhanced therapeutic efficacy and safety compared to conventional methods. This innovation allows for greater multivalency and multispecificity, producing biologic molecules with novel functionalities. Hinge Bio's products aim to tackle issues such as resistance and inadequate efficacy, catering primarily to healthcare institutions, research organizations, and pharmaceutical companies engaged in advanced therapeutic development in North America, Europe, and select markets in Asia.
Who invested in Hinge Bio
3 investors across 1 round
See all investors in Hinge Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 31, 2024
Amount
$31M
Investors
Questions about Hinge Bio
Who invested in Hinge Bio?
Hinge Bio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hinge Bio raised?
Hinge Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hinge Bio last raise money?
Hinge Bio's most recent round on record is a Series A, in Dec 2024.
What does Hinge Bio do?
Based in California, US, Hinge Bio, Inc.
Where is Hinge Bio headquartered?
Hinge Bio is headquartered in Burlingame, US.
Which VCs invest in companies like Hinge Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hinge Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hinge Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.